Senior Director, Search & Evaluation Late TA Lead

CSL Innovation(1 month ago)

HybridFull TimeDirector$185,568 - $246,177 (estimated)Search & Evaluation

About this role

Three Senior Directors of Search & Evaluation will lead strategic sourcing and evaluation of later-stage external clinical assets (Phase 2 to marketed) across Immunology, Hematology, and Cardiovascular/Renal therapeutic areas. They will help shape CSL’s late-stage external innovation portfolio through high-impact partnerships and transactions, leveraging deep clinical expertise and external scientific networks.

View Original Listing

Required Skills

Clinical Development
External Sourcing
KOL Engagement
Due Diligence
Portfolio Strategy
Deal Negotiation
Regulatory Knowledge
Market Access
Competitive Analysis
Cross-Functional Leadership

Qualifications

Advanced Degree (MD/PhD or equivalent)
MD
PhD

About CSL Innovation

csl.com

CSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.

View more jobs at CSL Innovation →